Hayat-Vax The UAE's COVID-19 Vaccine
- Publish date: Sunday، 05 December 2021
- Related articles
- Bahrain Approves Use of Oral COVID-19 Antiviral, Paxlovid
- Bahrain Approves Booster Shots for Those Aged 12 to 17
- Bahrain's MoH Recommends COVID-19 Bivalent Booster Shots for Children
After the UAE and China struck a major vaccine deal on Sunday night, the UAE announced that an Emirati drug maker is already producing Sinophram vaccine. The UAE vaccine will be known as Hayat-Vax, Hayat means 'life' in Arabic.
Officials said production could hit 2 million doses per month as Ras Al Khaimah drug maker Julphar is already rolling off a production line at Julphar's main plant in RAK.
"The new vaccine plant in Kizad will become operational this year and over its phased development will have a production capacity of 200 million doses per annum across three filling lines and five automated packaging lines," the release read.
.@abdullaalbasti: #Dubai is leveraging its integrated health services and strong precautionary regime to control COVID-19 as the Emirate aims to vaccinate 100% of Dubai’s eligible population.
— Dubai Media Office (@DXBMediaOffice) March 28, 2021
"The joint venture is already producing Hayat-Vax with its partner, Julphar in UAE with an initial capacity of 2 million doses per month."
RAK’s Julphar and Abu Dhabi's Group 42 said they would further build a dedicated facility in the capital's Kizad freezone.
“Life sciences and vaccine manufacturing in our country is UAE’s contribution towards global efforts to address the Covid-19 pandemic that has affected the whole world." Said Sheikh Abdullah bin Zayed, Minister of Foreign Affairs and International Co-operation.
Image Source: Instagram
This article was previously published on UAE Moments.To see the original article, click here